OptimizeRx (OPRX) Total Non-Current Liabilities (2010 - 2021)

OptimizeRx has disclosed Total Non-Current Liabilities across 12 years of filings, most recently posting $260614.0 for Q3 2021.

• In Q3 2021, Total Non-Current Liabilities fell 26.92% year-over-year to $260614.0; the TTM figure through Sep 2021 stood at $260614.0 (down 26.92% YoY), while the FY2020 annual figure was $325533.0, down 94.26% from the prior year.
• Total Non-Current Liabilities came in at $260614.0 for Q3 2021 at OptimizeRx, down from $282934.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $5.7 million in Q4 2019 to a low of $260614.0 in Q3 2021.
• Average Total Non-Current Liabilities over 5 years is $1.6 million, with a median of $1.6 million recorded in 2017.
• Year-over-year, Total Non-Current Liabilities surged 512.12% in 2017 and slumped 94.26% in 2020.
• Over 5 years, Total Non-Current Liabilities stood at $2.3 million in 2017, then advanced by 4.8% to $2.4 million in 2018, then jumped by 139.69% to $5.7 million in 2019, then tumbled by 94.26% to $325533.0 in 2020, then fell by 19.94% to $260614.0 in 2021.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $260614.0 in Q3 2021, $282934.0 in Q2 2021, and $305039.0 in Q1 2021.